Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Christ-Crain M, Opal SM.

Crit Care. 2010;14(1):203. doi: 10.1186/cc8155. Epub 2010 Feb 8. Review.

PMID:
20236471
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives.

Lippi G, Meschi T, Cervellin G.

Eur J Intern Med. 2011 Oct;22(5):460-5. doi: 10.1016/j.ejim.2011.02.023. Epub 2011 Mar 25. Review.

PMID:
21925053
[PubMed - indexed for MEDLINE]
3.

Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Pacheco EF, Dalla Rosa K.

Clinics (Sao Paulo). 2012 Nov;67(11):1321-5. Review.

PMID:
23184211
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Biomarkers and community-acquired pneumonia: tailoring management with biological data.

Torres A, Ramirez P, Montull B, Menéndez R.

Semin Respir Crit Care Med. 2012 Jun;33(3):266-71. doi: 10.1055/s-0032-1315638. Epub 2012 Jun 20. Review.

PMID:
22718212
[PubMed - indexed for MEDLINE]
5.

Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia?

Upadhyay S, Niederman MS.

Infect Dis Clin North Am. 2013 Mar;27(1):19-31. doi: 10.1016/j.idc.2012.11.003. Epub 2012 Dec 6. Review.

PMID:
23398863
[PubMed - indexed for MEDLINE]
6.

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.

Christ-Crain M, Müller B.

Eur Respir J. 2007 Sep;30(3):556-73. Review.

PMID:
17766633
[PubMed - indexed for MEDLINE]
Free Article
7.

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M.

BMC Infect Dis. 2007 Mar 2;7:10.

PMID:
17335562
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.

Niederman MS.

Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S127-32. doi: 10.1086/591393. Review.

PMID:
18986278
[PubMed - indexed for MEDLINE]
Free Article
9.

Biomarkers in community-acquired pneumonia.

Krüger S, Welte T.

Expert Rev Respir Med. 2012 Apr;6(2):203-14. doi: 10.1586/ers.12.6. Review.

PMID:
22455492
[PubMed - indexed for MEDLINE]
10.

Community acquired bacterial pneumonia.

Anevlavis S, Bouros D.

Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Review.

PMID:
20085502
[PubMed - indexed for MEDLINE]
11.

Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia.

Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, Höffken G.

Respir Med. 2012 Sep;106(9):1320-8. doi: 10.1016/j.rmed.2012.06.008. Epub 2012 Jun 23.

PMID:
22732597
[PubMed - indexed for MEDLINE]
Free Article
12.

Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.

Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F.

Clin Chem. 2007 Dec;53(12):2193-201. Epub 2007 Oct 19.

PMID:
17951293
[PubMed - indexed for MEDLINE]
Free Article
13.

Community-acquired pneumonia.

Cassiere HA, Niederman MS.

Dis Mon. 1998 Nov;44(11):613-75. Review.

PMID:
9858958
[PubMed - indexed for MEDLINE]
14.

Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.

Jereb M, Kotar T.

Wien Klin Wochenschr. 2006 Apr;118(5-6):170-4.

PMID:
16773483
[PubMed - indexed for MEDLINE]
15.

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1426-34. doi: 10.1164/rccm.201003-0415OC. Epub 2010 Jul 16.

PMID:
20639437
[PubMed - indexed for MEDLINE]
16.

Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.

Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A.

Crit Care Med. 2011 Oct;39(10):2211-7. doi: 10.1097/CCM.0b013e3182257445.

PMID:
21705887
[PubMed - indexed for MEDLINE]
17.

Biomarkers in the management of pneumonia.

Christ-Crain M, Schuetz P, Müller B.

Expert Rev Respir Med. 2008 Oct;2(5):565-72. doi: 10.1586/17476348.2.5.565.

PMID:
20477291
[PubMed]
18.

Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.

España PP, Capelastegui A, Bilbao A, Diez R, Izquierdo F, Lopez de Goicoetxea MJ, Gamazo J, Medel F, Salgado J, Gorostiaga I, Quintana JM; Population Study of Pneumonia (PSoP) Group.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3397-405. doi: 10.1007/s10096-012-1708-5. Epub 2012 Aug 5.

PMID:
23010902
[PubMed - indexed for MEDLINE]
19.

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.

Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group.

Eur Respir J. 2008 Feb;31(2):349-55. Epub 2007 Oct 24.

PMID:
17959641
[PubMed - indexed for MEDLINE]
Free Article
20.

Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia.

Lacoma A, Rodríguez N, Prat C, Ruiz-Manzano J, Andreo F, Ramírez A, Bas A, Pérez M, Ausina V, Domínguez J.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):825-33. doi: 10.1007/s10096-011-1381-0. Epub 2011 Aug 26.

PMID:
21870054
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk